Histone demethylase JMJD2D promotes the self-renewal of liver cancer stem-like cells by enhancing EpCAM and Sox9 expression

Autor: Qiang Chen, Chundong Yu, Ming Li, Yuan Deng, Minghui Zhuo, Peng Guo, Pingli Mo, Wengang Li
Rok vydání: 2020
Předmět:
0301 basic medicine
Male
Jumonji Domain-Containing Histone Demethylases
Lung Neoplasms
TGF-β
transforming growth factor-beta

Biochemistry
Metastasis
H3K9me3
TBE
TCF4 binding elements

Mice
Circulating tumor cell
Cell Movement
Cell Self Renewal
Wnt Signaling Pathway
Notch signaling
GFP
green fluorescent protein

Liver Neoplasms
Wnt signaling pathway
SOX9 Transcription Factor
Hep G2 Cells
CTCs
circulating tumor cells

Epithelial Cell Adhesion Molecule
ChIP
chromatin immunoprecipitation

Neoplastic Stem Cells
Heterografts
FACS
fluorescence-activated cell sorter

Liver cancer
Research Article
CSCs
cancer stem-like cells

LCSCs
liver cancer stem-like cells

Notch signaling pathway
Mice
Nude

Biology
03 medical and health sciences
FBS
fetal bovine serum

Cancer stem cell
Cell Line
Tumor

medicine
5-c-8HQ
Animals
Humans
Molecular Biology
Cell Proliferation
liver cancer stem-like cell
030102 biochemistry & molecular biology
JMJD2D
Co-IP
coimmunoprecipitation

SCNT
somatic cell nuclear transfer

Cell Biology
Transforming growth factor beta
DNA Methylation
medicine.disease
Wnt signaling
Mice
Inbred C57BL

030104 developmental biology
Cancer research
biology.protein
Chromatin immunoprecipitation
Zdroj: The Journal of Biological Chemistry
ISSN: 1083-351X
Popis: Cancer stem-like cells (CSCs) contribute to the high rate of tumor heterogeneity, metastasis, therapeutic resistance, and recurrence. Histone lysine demethylase 4D (KDM4D or JMJD2D) is highly expressed in colon and liver tumors, where it promotes cancer progression; however, the role of JMJD2D in CSCs remains unclear. Here, we show that JMJD2D expression was increased in liver cancer stem-like cells (LCSCs); downregulation of JMJD2D inhibited the self-renewal of LCSCs in vitro and in vivo and inhibited the lung metastasis of LCSCs by reducing the survival and the early lung seeding of circulating LCSCs. Mechanistically, JMJD2D promoted LCSC self-renewal by enhancing the expression of CSC markers EpCAM and Sox9; JMJD2D reduced H3K9me3 levels on the promoters of EpCAM and Sox9 to enhance their transcription via interaction with β-catenin/TCF4 and Notch1 intracellular domain, respectively. Restoration of EpCAM and Sox9 expression in JMJD2D-knockdown liver cancer cells rescued the self-renewal of LCSCs. Pharmacological inhibition of JMJD2D using 5-c-8HQ reduced the self-renewal of LCSCs and liver cancer progression. Collectively, our findings suggest that JMJD2D promotes LCSC self-renewal by enhancing EpCAM and Sox9 expression via Wnt/β-catenin and Notch signaling pathways and is a potential therapeutic target for liver cancer.
Databáze: OpenAIRE